J3032 Injection. eptinezumab-jjmr 1 milligrams
J-Codes
Also known as: eptinezumab, Vyepti, CGRP receptor antagonist
Eptinezumab-jjmr (Vyepti) 1 milligram injection is a monoclonal antibody targeting calcitonin gene-related peptide receptor for intravenous chronic migraine prevention.
Clinical Context
FDA-approved for chronic migraine prevention, administered intravenously every 12 weeks. Blocks calcitonin gene-related peptide receptor to reduce neuronal inflammation and migraine frequency in chronic migraine patients.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.